1 k markers and at later time points after
ACS remains uncertain.
2 and spreading, but its mechanisms of
action remain uncertain.
3 ssion by anemia, but its mechanism of
action remains uncertain.
4 ut the origin and functions of this
activity remain uncertain.
5 mplications for future thunderstorm
activity remain uncertain.
6 dentate mossy cells on hippocampal
activity remained uncertain despite a long history of investigati
7 metric approach to risk stratification of
AF remains uncertain.
8 iagnosis, age at diagnosis, and attained
age remains uncertain.
9 alt the extension of related cross-
allergies remains uncertain.
10 n the subsequent development of food
allergy remains uncertain.
11 hether epithelial differentiation is
altered remains uncertain.
12 role in the PNS has not been established
and remains uncertain.
13 surface uplift history of the Central
Andes remains uncertain.
14 angiospermae (~99.95% of extant
angiosperms)
remains uncertain, with multiple hypotheses reported in
15 cal and pathological effects of
APOEepsilon2 remain uncertain because of its relative rarity.
16 ts significance in the pathophysiology of
AR remains uncertain.
17 h acute respiratory distress syndrome (
ARDS)
remain uncertain.
18 cohorts that can be realistically
assembled remains uncertain.
19 lung carcinogenesis, but causal
associations remain uncertain.
20 isease process underlying these
associations remains uncertain.
21 lly modifiable exposures that lead to
asthma remain uncertain.
22 n movement disorders, but their neural
basis remains uncertain.
23 , as well as the impact of sex on this
bias,
remain uncertain.
24 cination alone without effective
biosecurity remains uncertain.
25 the high MeHg concentrations in Arctic
biota remains uncertain.
26 r, the nature and extent of any such
bonding remains uncertain.
27 of N saturation to the global carbon
budget remains uncertain due to the complicated nature of C-N (
28 ons for air quality and climate forcing,
but remains uncertain especially in tropical areas with exte
29 low-density lipoprotein cholesterol (LDL-
C)
remains uncertain.
30 nfections that result in clinical cases,
can remain uncertain for a prolonged period of time.
31 treatment of patients with esophageal
cancer remains uncertain.
32 mune system in targeting early-stage
cancers remains uncertain.
33 the boron reagent to the palladium
catalyst remains uncertain.
34 vels and cardiometabolic diseases,
causality remains uncertain.
35 The physiological
causes remain uncertain, although impaired myometrial function
36 dergoing concurrent chemoradiotherapy (
CCRT)
remains uncertain.
37 of this calcium-dependent facilitation (
CDF)
remains uncertain, however, in large measure because the
38 ceptor (GIPR) for the function of beta
cells remains uncertain.
39 How this is realized in 21st
century remains uncertain, in large part due to limitations on p
40 controlling natriuretic-peptide-coupled
cGMP remain uncertain.
41 their predicted responses to climate
change remain uncertain.
42 e regions and their impact on climate
change remain uncertain.
43 ote adaptation in response to climate
change remains uncertain.
44 of soil respiration to precipitation
changes remain uncertain in terrestrial ecosystems.
45 hanges in TC activity under a warmer
climate remain uncertain, particularly in terms of TC genesis lo
46 mental artifact from ion-molecule
clustering remains uncertain.
47 imate Model Intercomparison Project (
CMIP5),
remain uncertain.
48 otein partners to form the shelterin
complex remains uncertain.
49 interactions with different LHCII
complexes remain uncertain.
50 which group is responsible for this
culture remains uncertain.
51 n (C) nitrogen (N) and phosphorus (P)
cycles remains uncertain.
52 sed to other consequences of hearing
damage,
remain uncertain.
53 al link between contaminants and
deformities remains uncertain, and suggest improved experimental and
54 threshold value associated with
deglaciation remains uncertain.
55 own; however, the mechanism of
dephytylation remains uncertain.
56 at compared with other adipose tissue
depots remains uncertain.
57 f newer-generation drug-eluting stents (
DES)
remains uncertain.
58 ecule in the context of rational drug
design remains uncertain.
59 ormation of NH3 from N2, mechanistic
details remain uncertain.
60 The risk associated with insulin
detemir remains uncertain because there are fewer users of this
61 lationship (s) and sex-specific
determinants remain uncertain.
62 ology studies on subsequent drug
development remains uncertain.
63 and mortality among persons without
diabetes remain uncertain.
64 mes but risks beyond 30 years from
diagnosis remain uncertain.
65 to be inherited, but in many cases
diagnosis remains uncertain.
66 analyse these two critical sound
dimensions remains uncertain.
67 stiffness in the absence of vascular
disease remains uncertain.
68 revention of multifactorial chronic
diseases remains uncertain, and there is sparse evidence regardin
69 cemic load (GL) with psychological
disorders remain uncertain.
70 ent to which they are functionally
distinct,
remain uncertain.
71 ting their maintenance or exit from
dormancy remain uncertain.
72 r, the climate sensitivity of this
ecosystem remains uncertain: several studies have predicted large-
73 endence of respiration in aquatic
ecosystems remain uncertain.
74 The carbon balance of tropical
ecosystems remains uncertain, with top-down atmospheric studies sug
75 are available, but their cost-
effectiveness remains uncertain.
76 treatment of chronic pain, yet its
efficacy remains uncertain.
77 rates, the outcome of their advocacy
efforts remains uncertain.
78 ions in controlling Arctic methane
emissions remains uncertain.
79 marine biotic recovery versus CAMP
eruptions remains uncertain.
80 ir phylogenetic placement within the
Eukarya remains uncertain.
81 -term, regional trends in
evapotranspiration remain uncertain due to spatially and temporally limited
82 e splenectomy, but predictors of such
events remain uncertain.
83 subsurface/atmospheric natural gas
exchange remain uncertain.
84 e specifics of these catastrophic
explosions remain uncertain, due partly to limited observational co
85 of their ecology, evolution, and
extinction remain uncertain.
86 ver, the role of one important family,
FGFs,
remains uncertain.
87 y, the clinical significance of this
finding remains uncertain, because no adverse outcomes were repo
88 ecular mechanism underlying lysosome
fission remains uncertain.
89 f changes in snow accumulation on CH4
fluxes remain uncertain.
90 ange and how it causes this gain-of-
function remain uncertain.
91 s and chronic inflammation, but its
function remains uncertain.
92 conserved or differential neuronal
function remains uncertain.
93 hese interactions might change in the
future remain uncertain.
94 ver-stage Plasmodium downstream of IFN-
gamma remains uncertain, however.
95 M) after gestational diabetes mellitus (
GDM)
remains uncertain.
96 protein ubiquitylation to peptide
generation remains uncertain.
97 The role of bevacizumab for
glioblastoma remains uncertain but will likely be strongly influenced
98 Health Organization's 2020 elimination
goals remains uncertain.
99 hese responses along environmental
gradients remain uncertain.
100 rs determining prehistoric population
growth remain uncertain.
101 ole of interleukin (IL)-17 and IL-22 in
GVHD remains uncertain, due to an apparent lack of lineage fi
102 The formation pathways of
gypsum remain uncertain.
103 the NTPase domain in cluster biogenesis
has remained uncertain.
104 tenin complex to the actin cytoskeleton,
has remained uncertain.
105 frontal cortex in speech production, it
has remained uncertain whether the frontal cortex in nonhuma
106 Its phylogenetic position
has remained uncertain and it has been compared with nemerte
107 on calcium-dependent inactivation (CDI)
have remained uncertain.
108 ts kinase activity and channel function
have remained uncertain.
109 ces of chronic insufficient sleep for
health remain uncertain.
110 ons of exposure to bullying to mental
health remains uncertain, as noncausal relationships may arise
111 ough the atomic structure of Hsp104
hexamers remains uncertain, volumetric reconstruction of Hsp104 h
112 thern Oscillation (ENSO) during the
Holocene remains uncertain.
113 erminants of WNV spread in its natural
hosts remain uncertain.
114 c position of this enigmatic group,
however,
remained uncertain.
115 ategic utility of these new agents,
however,
remains uncertain, and further studies will be required
116 promote bone healing; its efficacy,
however,
remains uncertain.
117 f these plots for regional forests,
however,
remains uncertain because we lack an assessment of wheth
118 The lifespan of brain microglia,
however,
remains uncertain, and reflects confounding factors in e
119 s and health-related quality of life (
HRQOL)
remains uncertain.
120 for BP in patients with CKD and
hypertension remains uncertain.
121 re (SBP) in older patients with
hypertension remains uncertain.
122 he adaptation by gene duplication
hypothesis remains uncertain.
123 eased mortality; however, the overall
impact remains uncertain.
124 effective ways to deliver health
incentives remain uncertain.
125 ssor phenotype of these infected
individuals remains uncertain.
126 n between CA-MRSA colonization and
infection remains uncertain.
127 against Mycobacterium tuberculosis
infection remains uncertain.
128 oreceptors that generates lateral
inhibition remains uncertain.
129 ular details of the PrP(C)-Abeta
interaction remain uncertain.
130 rbon-climate interactions over this
interval remain uncertain.
131 em cells (HSCs), but the mechanisms
involved remain uncertain.
132 nce and effector pathway locally in the
iris remain uncertain.
133 It remains uncertain though which hosts they rely upon, and
134 It remains uncertain whether kidney transplant recipients a
135 It remains uncertain whether NLRP3 surveys mitochondrial in
136 It remains uncertain whether prophylactic exclusion of the
137 It remains uncertain whether recurrent nonsevere hypoglycem
138 It remains uncertain whether such Ca(2+)-dependent adaptati
139 It remains uncertain whether the association between CRP co
140 It remains uncertain, however, to what extent biogeochemica
141 It remains uncertain, however, to what extent temperature a
142 It remains uncertain, however, whether BAT (18)F-FDG uptake
143 It remains uncertain, however, whether tree mortality acros
144 e for such a role is sparse, however, and
it remains uncertain how that role relates to the disparate
145 even a formal [4 + 2] cycloaddition, and
it remains uncertain if any of them proceed via the Diels-A
146 ult weight trajectory with mortality, and
it remains uncertain whether associations differ by race or
147 l effects of anionophores are scarce, and
it remains uncertain whether such molecules are fundamental
148 endothelial control of vascular tone but
it remains uncertain (1) how pressure is sensed by the endo
149 But
it remains uncertain whether the utility values obtained by
150 studied extensively in recombinant cells,
it remains uncertain whether native receptors expressed in
151 ifferences with current radiative forcing
it remains uncertain if the Pacific will react in a similar
152 However,
it remains uncertain how effective these drugs will be for
153 However,
it remains uncertain whether modified nucleosomes play a ca
154 However,
it remains uncertain whether or not various forms of decisi
155 pared with control participants; however,
it remains uncertain whether reduced levels precede dementi
156 ) are classified as better risk; however,
it remains uncertain whether this favorable classification
157 ine models have provided key information,
it remains uncertain to what extent these basic mechanisms
158 ts with acute myocardial infarction (MI),
it remains uncertain whether there is a time-dependent diff
159 ected non-small-cell lung cancer (NSCLC),
it remains uncertain whether this approach is superior to s
160 us cycle over the past 3.5 billion years,
it remains uncertain whether phosphorus limitation persiste
161 Although future freshwater pCO2
levels remain uncertain, studies have considered the potential
162 mplications of these variable protein
levels remain uncertain.
163 influence of increased total chlorine
levels remains uncertain.
164 es, but the risk at high birth weight
levels remains uncertain.
165 ells, but the role of individual Wnt
ligands remains uncertain.
166 unruptured brain arteriovenous
malformations remains uncertain.
167 er, the underlying disease-causing
mechanism remains uncertain.
168 l hyperalgesia, but the underlying
mechanism remains uncertain.
169 ons; yet, the underlying biologic
mechanisms remain uncertain.
170 ular morbidity and mortality, but
mechanisms remain uncertain.
171 Alzheimer's disease (AD) but the
mechanisms remain uncertain.
172 mong synapses, but the underlying
mechanisms remain uncertain.
173 ular dopamine, but the underlying
mechanisms remain uncertain.
174 uelled by, gas from the intergalactic
medium remain uncertain.
175 eir impact on the gut's bacterial
microbiota remains uncertain.
176 However, the precise mechanisms of
mitophagy remain uncertain.
177 ts in reducing clinical sepsis and
mortality remain uncertain.
178 gh definite reductions in maternal
mortality remain uncertain, concurrent improvements in essential m
179 flavonoids in preventing all-cause
mortality remains uncertain.
180 brain injury, the prognostic utility of
MRI remains uncertain.
181 (+)-binding sites (termed Na1 and Na2),
much remains uncertain in regard to the movements and contrib
182 earth's magnetic field, yet in sharks,
much remains uncertain regarding the sensory receptors and pa
183 the mechanisms underlying
neurodegeneration remain uncertain, evidence supports a proteotoxic role f
184 mechanism how Notch works in mature
neurons remains uncertain.
185 onsteroidal antiinflammatory drugs (
NSAIDs),
remains uncertain.
186 on trends and the disease burden of
obesity remain uncertain.
187 ng modality, and current therapeutic
options remain uncertain but are rapidly evolving.
188 er, but their cellular and molecular
origins remain uncertain.
189 flow between populations, but their
origins remain uncertain.
190 nsorimotor beta-band (15-25 Hz)
oscillations remains uncertain.
191 eration resulting in good functional
outcome remains uncertain and unnecessary delays to treatment ma
192 lization and its effect on long-term
outcome remains uncertain.
193 mutations on clinical phenotype and
outcomes remains uncertain.
194 fonylurea therapy on cardiovascular
outcomes remains uncertain.
195 sociated effect on patient-centered
outcomes remains uncertain.
196 ; however, their effect on clinical
outcomes remains uncertain.
197 ndings will translate into improved
outcomes remains uncertain.
198 ing, and whether it yields improved
outcomes remains uncertain.
199 imary productivity in the equatorial
Pacific remains uncertain.
200 role of depression in recall of dental
pain remains uncertain.
201 uch a pervasive pattern in the geologic
past remains uncertain.
202 s, but the clinical picture and
pathogenesis remain uncertain.
203 al symptom of HFpEF, yet its
pathophysiology remains uncertain.
204 the physiological importance of this
pathway remains uncertain especially in the setting of high plas
205 the activation of other detrimental
pathways remains uncertain.
206 nefit of VKAs in dialysis-dependent
patients remains uncertain, although some evidence suggests that
207 ptimal chemotherapy dosing in obese
patients remains uncertain, with variation in practice.
208 VR, the optimal management of these
patients remains uncertain and controversial.
209 ter percutaneous coronary intervention (
PCI)
remains uncertain, with some studies finding in favor of
210 e of parkinsonism and Parkinson disease (
PD)
remain uncertain.
211 optimal treatment for many phenotypes of
PE remains uncertain.
212 e ice sheet during past interglacial
periods remains uncertain.
213 Mechanisms of
persistence remain uncertain, but integration of the provirus into t
214 significance of the index cardiac
phenotype remains uncertain.
215 ontribution of the biofilm's conductive
pili remains uncertain, largely because pili-defective mutant
216 hin Spiralia, although their exact
placement remains uncertain.
217 after coronary drug-eluting stent
placement remains uncertain.
218 bundant sterol derivatives in higher
plants,
remains uncertain.
219 hip between neural and behavioral
plasticity remains uncertain.
220 enomenon, but the role that complement
plays remains uncertain.
221 nt restenosis, the benefit of DCBA over
POBA remains uncertain.
222 , effectiveness of land consolidation
policy remains uncertain.
223 y-related diseases in the general
population remains uncertain.
224 ert Ultra cartridge in different
populations remain uncertain.
225 ease, but its functional oncogenic
potential remains uncertain.
226 or caused by insufficient statistical
power remains uncertain.
227 estimated risks are imprecise and
predictors remain uncertain.
228 ing RAD51D variants to cancer
predisposition remains uncertain.
229 es in the circadian rhythm of blood
pressure remains uncertain.
230 ng-term maintenance of this cellular
priming remain uncertain.
231 the mechanisms responsible for this
process remain uncertain.
232 but the molecular mechanisms of this
process remain uncertain.
233 and precipitation and terrestrial
processes remains uncertain.
234 the actual market for an individual
product remains uncertain.
235 ures occur naturally in HSCs and
progenitors remains uncertain.
236 s pathological driver of disease
progression remains uncertain.
237 bsequently recovered, but future
projections remain uncertain.
238 pe bacterial and archaeal genomic
properties remain uncertain (3-7) .
239 oxidation catalysis, the active phase of
Pt remains uncertain, even for the Pt(111) single-crystal s
240 r prophylactic ablation and its success
rate remain uncertain.
241 the regulation of TGF-beta type II
receptor remains uncertain.
242 D-glucan (BG) in liver transplant
recipients remains uncertain.
243 actors governing plasma membrane
recruitment remain uncertain.
244 ted to modulate this process, its
regulation remains uncertain.
245 associations represent causal
relationships remains uncertain.
246 on routes of alpha and delta granule
release remain uncertain.
247 of TGF-beta signaling in female
reproduction remain uncertain.
248 However, the magnitude of this
response remains uncertain as the constraints are abiotic, biotic
249 e net global balance between these
responses remains uncertain.
250 ly for species with multiple or fused
rings)
remains uncertain.
251 e in response to oxidative stress, this
role remains uncertain, and results lack in vivo models.
252 osed, the true biological function of
Rv3802 remains uncertain.
253 articularly within the context of
screening,
remain uncertain.
254 ORC2-activated Akt signaling in this
setting remains uncertain.
255 om positive to negative among plant
species,
remain uncertain.
256 the chronological age of many key
specimens remains uncertain.
257 ns in the regulation of alternative
splicing remain uncertain.
258 alyses into "Platyzoa," a clade whose
status remains uncertain [1, 8-11].
259 , a highly migratory population whose
status remains uncertain.
260 utaneous coronary intervention with
stenting remains uncertain.
261 errestrial surfaces and the atmosphere
still remain uncertain.
262 exact nature and quantitation of HBeAg
still remain uncertain.
263 efficacy of these interventional
strategies remains uncertain.
264 ity, but the appropriate management
strategy remains uncertain.
265 of bromine and the input to the
stratosphere remains uncertain.
266 nique in patients with acute ischemic
stroke remain uncertain because of lack of evidence from random
267 ation to build and maintain these
structures remain uncertain because of the challenges of consistent
268 CRT-D in patients with NYHA class I
symptoms remains uncertain.
269 , yet its efficacy in treating PTSD
symptoms remains uncertain.
270 ve-compulsive disorder and Tourette
syndrome remain uncertain.
271 ivities and its effect on the climate
system remains uncertain.
272 rudiment of the adult haematopoietic
system,
remains uncertain.
273 rocesses in vivo and are therapeutic
targets remains uncertain.
274 r, reconstructions of LIG global
temperature remain uncertain, with estimates ranging from no signifi
275 d by prostate-specific antigen (PSA)
testing remains uncertain.
276 e utility of triglyceride-lowering
therapies remains uncertain, 2 large clinical trials are testing t
277 from intensification of antiplatelet
therapy remains uncertain.
278 ction, but the clinical implications of
this remain uncertain.
279 of direct RAS binding to PI3-Kinase in
this remains uncertain.
280 f light activity and risk for sedentary
time remain uncertain.
281 revalence and function of RNA
topoisomerases remain uncertain.
282 ure trend over the extensive northwestern
TP remains uncertain due to few meteorological stations.
283 in AF, the optimal antithrombotic
treatment remains uncertain for primary protection against MI.
284 the cardiovascular safety of this
treatment remains uncertain and will require evaluation in a new a
285 worldwide, yet associations between the
two remain uncertain.
286 nfection via single genome samples
typically remains uncertain.
287 y and the mechanism involved in GQ
unfolding remain uncertain.
288 equently, the active receptor signaling
unit remains uncertain.
289 timal approach to Ag delivery by
vaccination remains uncertain.
290 are clinically used; however, their
validity remains uncertain considering ongoing changes in the pan
291 IRAP translocation to inactivate
vasopressin remains uncertain.
292 hicles with more fuel efficient GDI
vehicles remain uncertain.
293 their interactions with respiratory
viruses remain uncertain.
294 ctating their formation and function in
vivo remains uncertain.
295 s (ASICs) in the ventrolateral medulla (
VLM)
remains uncertain.
296 neutralization when transmitting through
VS remains uncertain.
297 tionation for whole-breast irradiation (
WBI)
remains uncertain.
298 art of the properties of GH32 enzymes,
which remain uncertain, like their allosteric character.
299 e results suggest program effectiveness
will remain uncertain in the absence of requiring monitoring
300 ctiveness of vaccinating beyond age 22
years remains uncertain.